Patient Registry Software Market by Type of Registry (Diabetes, Cancer, Rare Disease, Asthma, Kidney), Software (Integrated and Standalone), Delivery (On Premise and Cloud), Pricing Model, Database (Public), End User (Hospitals) - Global Forecast to 2026
The global patient registry software market is projected to reach USD 2.8 billion by 2026 from USD 1.4 billion in 2021, at a CAGR of 15.0% during the forecast period. The growth of this market is mainly attributed to the shift toward computerized registries to provide users with an automated way to store data and create, sort, and display patient lists for use in planning, quality improvement, reporting, and direct care delivery. Also, the emergence of the COVID-19 pandemic and the increasing number of COVID-19 patients globally are expected to increase the demand for patient registry software in the coming years. Moreover, factors such as rising number of accountable care organizations and high adoption rate of the subscription model are creating lucrative opportunities for the market players.
“Diseases Registries was the largest and fastest-growing segment in the type of registry market in 2020”
Disease registries accounted for the largest share of patient registry software market in 2020. Factors such as the increasing government initiatives to develop and maintain patient health records (to reduce healthcare costs) and the growing awareness about collecting and utilizing patient health information are driving the adoption of disease registries.
“Government organizations & TPAs is the largest end user segment in the patient registry software market in 2020”
Based on the end user, the patient registry software market is segmented into private payers; hospitals & medical practices; research centers; pharmaceutical, biotechnology, & medical device companies; and government organizations & TPAs. In 2020, the government organizations & TPAs segment accounted for the largest share of the global patient registry software market. The large share of this segment can be attributed to the emergence of the COVID-19 pandemic and the need for analyzing patient data for better population health management.
“APAC to witness the highest growth rate during the forecast period.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by the increasing need to integrate healthcare systems, government funding for developing patient registries, rising focus on PHM and HIE, high demand for EHRs in Asian countries.
The break-down of primary participants is as mentioned below:
The key players operating in the patient registry software market include IBM Corporation (US), IQVIA Holdings (US), OpenText Corporation (Canada), Optum (US), Premier, Inc. (US), ArborMetrix, Inc. (US), FIGmd (US), McKesson Corporation (US), Syneos Health (US), Dacima Software, Inc. (Canada), ifa Systems AG (Germany).
Research Coverage:
The report analyzes the patient registry software market and aims at estimating the market size and future growth potential of various market segments, based on type of registry, type of software, pricing model, deployment model, type of database, functionality, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
“Diseases Registries was the largest and fastest-growing segment in the type of registry market in 2020”
Disease registries accounted for the largest share of patient registry software market in 2020. Factors such as the increasing government initiatives to develop and maintain patient health records (to reduce healthcare costs) and the growing awareness about collecting and utilizing patient health information are driving the adoption of disease registries.
“Government organizations & TPAs is the largest end user segment in the patient registry software market in 2020”
Based on the end user, the patient registry software market is segmented into private payers; hospitals & medical practices; research centers; pharmaceutical, biotechnology, & medical device companies; and government organizations & TPAs. In 2020, the government organizations & TPAs segment accounted for the largest share of the global patient registry software market. The large share of this segment can be attributed to the emergence of the COVID-19 pandemic and the need for analyzing patient data for better population health management.
“APAC to witness the highest growth rate during the forecast period.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by the increasing need to integrate healthcare systems, government funding for developing patient registries, rising focus on PHM and HIE, high demand for EHRs in Asian countries.
The break-down of primary participants is as mentioned below:
- By Company Type - Tier 1: 35%, Tier 2: 45%, and Tier 3: 20%
- By Designation - C-level: 35%, Director-level: 25%, and Others: 40%
- By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, and Rest of the World: 5%.
The key players operating in the patient registry software market include IBM Corporation (US), IQVIA Holdings (US), OpenText Corporation (Canada), Optum (US), Premier, Inc. (US), ArborMetrix, Inc. (US), FIGmd (US), McKesson Corporation (US), Syneos Health (US), Dacima Software, Inc. (Canada), ifa Systems AG (Germany).
Research Coverage:
The report analyzes the patient registry software market and aims at estimating the market size and future growth potential of various market segments, based on type of registry, type of software, pricing model, deployment model, type of database, functionality, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the patient registry software market. The report analyzes this market by type of registry, type of software, pricing model, deployment model, type of database, functionality, end user, and region.
- Market Development: Comprehensive information on the lucrative emerging markets, type of registry, type of software, pricing model, deployment model, type of database, functionality, end user, and region
- Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the patient registry software market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the patient registry software market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKET SEGMENTATION
FIGURE 1 PATIENT REGISTRY SOFTWARE MARKET
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
TABLE 1 EXCHANGE RATES USED FOR CONVERSION TO USD
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE PATIENT REGISTRY SOFTWARE MARKET (2021-2026)
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 8 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: PATIENT REGISTRY SOFTWARE MARKET
3 EXECUTIVE SUMMARY
FIGURE 9 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2021 VS. 2026 (USD MILLION)
FIGURE 10 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2021 VS. 2026 (USD MILLION)
FIGURE 11 PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2021 VS. 2026 (USD MILLION)
FIGURE 12 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2021 VS. 2026 (USD MILLION)
FIGURE 13 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2021 VS. 2026 (USD MILLION)
FIGURE 14 PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021 VS. 2026 (USD MILLION)
FIGURE 15 PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF PATIENT REGISTRY SOFTWARE MARKET
4 PREMIUM INSIGHTS
4.1 PATIENT REGISTRY SOFTWARE MARKET OVERVIEW
FIGURE 17 RISING ADOPTION OF ELECTRONIC HEALTH RECORDS AND OTHER E-HEALTH SOLUTIONS DRIVING MARKET
4.2 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY AND COUNTRY (2020)
FIGURE 18 DISEASE REGISTRIES SEGMENT AND JAPAN ACCOUNTED
FOR LARGEST SHARES
4.3 PATIENT REGISTRY SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
4.4 REGIONAL MIX: PATIENT REGISTRY SOFTWARE MARKET (2021?2026)
FIGURE 20 NORTH AMERICA TO DOMINATE PATIENT REGISTRY
SOFTWARE MARKET IN 2026
4.5 PATIENT REGISTRY SOFTWARE MARKET: DEVELOPING VS. DEVELOPED MARKETS
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 PATIENT REGISTRY SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Government initiatives to build patient registries
5.2.1.2 Rising pressure to improve quality of care and reduce
healthcare costs
5.2.1.3 Rising adoption of EHRs and other eHealth solutions
5.2.1.4 Growing patient volume due to global outbreak of COVID-19
5.2.1.5 Growing use of patient registry data for post-marketing surveillance
5.2.2 MARKET RESTRAINTS
5.2.2.1 Privacy- and data security-related concerns
5.2.2.2 Shortage of trained and skilled resources
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Rising number of accountable care organizations
5.2.3.2 Emergence of cloud-based patient registry solutions
5.2.3.3 High adoption rate of subscription model
5.2.4 MARKET CHALLENGES
5.2.4.1 Lack of interoperability and integration
5.2.4.2 Reluctance to adopt advanced solutions
5.2.4.3 Lack of awareness
5.3 REGULATORY ANALYSIS
TABLE 3 KEY REGULATIONS & STANDARDS GOVERNING MEDICAL DEVICE CONNECTIVITY SOLUTIONS
5.3.1 INTEROPERABILITY STANDARDS
TABLE 4 KEY STANDARDS FOR INTEROPERABILITY IN DIGITAL HEALTH SPECTRUM
TABLE 5 QUALITATIVE ANALYSIS OF WIDELY USED DATA TRANSMISSION STANDARDS IN DIGITAL HEALTH SPECTRUM
5.4 PRICING ANALYSIS
5.5 TECHNOLOGY ANALYSIS
5.6 ECOSYSTEM ANALYSIS
FIGURE 23 ECOSYSTEM ANALYSIS: PATIENT REGISTRY SOFTWARE MARKET
5.7 PATENT ANALYSIS
5.7.1 PATENT PUBLICATION TRENDS FOR PATIENT REGISTRY SOFTWARE
FIGURE 24 PATENT PUBLICATION TRENDS (JANUARY 2011–JUNE 2021)
5.7.2 JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 25 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR PATIENT REGISTRIES PATENTS (JANUARY 2011 TO JUNE 2021)
FIGURE 26 TOP APPLICANT COUNTRIES/REGIONS FOR PATIENT REGISTRY SOFTWARE PATENTS (JANUARY 2011 TO JUNE 2021)
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 SHIFTING FOCUS TOWARD PATIENT-POWERED RESEARCH NETWORKS
6.2.2 GROWING DEVELOPMENTS IN AUTOMATED DATA ENTRIES
6.3 IMPACT OF COVID-19 ON PATIENT REGISTRY SOFTWARE MARKET
7 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY
7.1 INTRODUCTION
TABLE 6 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 7 PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2 DISEASE REGISTRIES
TABLE 8 DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 9 DISEASE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.1 DIABETES REGISTRIES
7.2.1.1 Growing obese and geriatric populations to drive market growth
TABLE 10 DIABETES REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 11 DIABETES REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2 CARDIOVASCULAR REGISTRIES
7.2.2.1 Rising prevalence of heart diseases and strokes worldwide to drive market growth
TABLE 12 CARDIOVASCULAR REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 13 CARDIOVASCULAR REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.3 CANCER REGISTRIES
7.2.3.1 Increasing need to manage growing number of cancer patients to propel market growth
TABLE 14 CANCER REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 15 CANCER REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.4 RARE DISEASE REGISTRIES
7.2.4.1 Increasing funding for research on rare diseases and their treatments to boost market growth
TABLE 16 RARE DISEASE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 17 RARE DISEASE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.5 ASTHMA REGISTRIES
7.2.5.1 Increasing prevalence of asthma significantly driving market growth
TABLE 18 ASTHMA REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 19 ASTHMA REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.6 CHRONIC KIDNEY DISEASE REGISTRIES
7.2.6.1 Rising prevalence of chronic kidney diseases to drive market growth
TABLE 20 CHRONIC KIDNEY DISEASE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 21 CHRONIC KIDNEY DISEASE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.7 ORTHOPEDIC REGISTRIES
7.2.7.1 Growing number of patients suffering from orthopedic diseases to drive market growth
TABLE 22 ORTHOPEDIC REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 23 ORTHOPEDIC REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.8 OTHER DISEASE REGISTRIES
TABLE 24 OTHER DISEASE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 HEALTH SERVICE REGISTRIES
7.3.1 CAPTURE SERVICE-GENERATED DATA DERIVED FROM HEALTH FACILITIES
TABLE 25 HEALTH SERVICE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 26 HEALTH SERVICE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4 PRODUCT REGISTRIES
TABLE 27 PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 28 PRODUCT REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.1 MEDICAL DEVICE REGISTRIES
7.4.1.1 Strong government support and initiatives to drive demand for medical device registries
TABLE 29 MEDICAL DEVICE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 30 MEDICAL DEVICE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.2 DRUG REGISTRIES
7.4.2.1 Increasing post-marketing surveillance of drugs to
drive market growth
TABLE 31 DRUGS REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 32 DRUG REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
8 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE
8.1 INTRODUCTION
TABLE 33 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
8.2 STANDALONE SOFTWARE
8.2.1 STANDALONE SOFTWARE TO DOMINATE MARKET IN FORECAST PERIOD
TABLE 34 STANDALONE SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 35 STANDALONE PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 INTEGRATED SOFTWARE
8.3.1 INTEGRATED SOFTWARE SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
TABLE 36 INTEGRATED SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 37 INTEGRATED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
9 PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL
9.1 INTRODUCTION
TABLE 38 PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
9.2 SUBSCRIPTION MODEL
9.2.1 LOW COST OF SUBSCRIPTION MODELS TO SUPPORT SEGMENT GROWTH
TABLE 39 SUBSCRIPTION-BASED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
9.3 OWNERSHIP MODEL
9.3.1 RISING ADOPTION OF INTEGRATED SOFTWARE MODEL TO SUPPORT SEGMENT GROWTH
TABLE 40 OWNERSHIP-BASED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
10 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL
10.1 INTRODUCTION
TABLE 41 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
10.2 ON-PREMISE MODEL
10.2.1 ON-PREMISE SOLUTIONS REDUCE RISK OF DATA BREACHES AND OTHER SECURITY ISSUES
TABLE 42 ON-PREMISE PATIENT REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 43 ON-PREMISE PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
10.3 CLOUD-BASED MODEL
10.3.1 CLOUD-BASED SOLUTIONS HELP HEALTHCARE ORGANIZATIONS SHARE AND INTEGRATE INFORMATION FROM DISPARATE LOCATIONS IN REAL-TIME
TABLE 44 CLOUD-BASED PATIENT REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 45 CLOUD-BASED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
11 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE
11.1 INTRODUCTION
TABLE 46 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
11.2 COMMERCIAL DATABASES
11.2.1 COMMERCIAL REGISTRIES ARE GENERALLY PRIVATELY FUNDED OR INDUSTRY-SPONSORED
TABLE 47 PATIENT REGISTRY SOFTWARE FOR COMMERCIAL DATABASES OFFERED
BY KEY MARKET PLAYERS
TABLE 48 PATIENT REGISTRY SOFTWARE MARKET FOR COMMERCIAL DATABASES, BY COUNTRY, 2019–2026 (USD MILLION)
11.3 PUBLIC DATABASES
11.3.1 PUBLIC REGISTRIES ARE FUNDED BY FEDERAL, STATE, OR LOCAL GOVERNMENT AGENCIES
TABLE 49 PATIENT REGISTRY SOFTWARE FOR PUBLIC DATABASES OFFERED
BY KEY MARKET PLAYERS
TABLE 50 PATIENT REGISTRY SOFTWARE MARKET FOR PUBLIC DATABASES, BY COUNTRY, 2019–2026 (USD MILLION)
12 PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY
12.1 INTRODUCTION
TABLE 51 PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
12.2 POPULATION HEALTH MANAGEMENT
12.2.1 INCREASING DEMAND FOR QUALITY CARE DRIVES ADOPTION
OF PHM SOLUTIONS
TABLE 52 PATIENT REGISTRY SOFTWARE MARKET FOR POPULATION HEALTH MANAGEMENT, BY COUNTRY, 2019–2026 (USD MILLION)
12.3 PATIENT CARE MANAGEMENT
12.3.1 GOVERNMENT INITIATIVES AND REGULATIONS PROMOTING PATIENT-CENTRIC CARE TO DRIVE MARKET GROWTH
TABLE 53 PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT CARE MANAGEMENT, BY COUNTRY, 2019–2026 (USD MILLION)
12.4 MEDICAL RESEARCH & CLINICAL STUDIES
12.4.1 CONTINUOUS RESEARCH FOR COVID-19 VACCINE SUPPORTING
SEGMENT GROWTH
TABLE 54 PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL RESEARCH & CLINICAL STUDIES, BY COUNTRY, 2019–2026 (USD MILLION)
12.5 HEALTH INFORMATION EXCHANGE
12.5.1 INCREASING NEED FOR SHARING OF VITAL PATIENT INFORMATION WITH CARE PROVIDERS SUPPORTS ADOPTION OF SOLUTIONS
TABLE 55 PATIENT REGISTRY SOFTWARE MARKET FOR HEALTH INFORMATION EXCHANGE, BY COUNTRY, 2019–2026 (USD MILLION)
12.6 POINT OF CARE
12.6.1 URGENT NEED FOR STREAMLINED PATIENT CARE PROCESS
TO DRIVE GROWTH
TABLE 56 PATIENT REGISTRY SOFTWARE MARKET FOR POINT OF CARE, BY COUNTRY, 2019–2026 (USD MILLION)
12.7 PRODUCT OUTCOME EVALUATION
12.7.1 INCREASING POST-MARKETING SURVEILLANCE IN BIOTECHNOLOGY AND MEDICAL DEVICE COMPANIES TO PROPEL MARKET GROWTH
TABLE 57 PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT OUTCOME EVALUATION, BY COUNTRY, 2019–2026 (USD MILLION)
13 PATIENT REGISTRY SOFTWARE MARKET, BY END-USER
13.1 INTRODUCTION
TABLE 58 PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2019–2026 (USD MILLION)
13.2 GOVERNMENT ORGANIZATIONS & THIRD-PARTY ADMINISTRATORS
13.2.1 GOVERNMENT ORGANIZATIONS & THIRD-PARTY ADMINISTRATORS HOLD LARGEST SHARE IN END-USER MARKET
TABLE 59 PATIENT REGISTRY SOFTWARE MARKET FOR GOVERNMENT ORGANIZATIONS & TPAS, BY COUNTRY, 2019–2026 (USD MILLION)
13.3 HOSPITALS & MEDICAL PRACTICES
13.3.1 DEMAND FOR REGISTRY SOFTWARE SUPPORTED BY A GROWING FOCUS ON PATIENT SAFETY AND IMPROVING PATIENT OUTCOMES
TABLE 60 PATIENT REGISTRY SOFTWARE MARKET FOR HOSPITALS & MEDICAL PRACTICES, BY COUNTRY, 2019–2026 (USD MILLION)
13.4 PRIVATE PAYERS
13.4.1 NEED TO CURB RISING HEALTHCARE COSTS TO DRIVE MARKET GROWTH
TABLE 61 PATIENT REGISTRY SOFTWARE MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2019–2026 (USD MILLION)
13.5 PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES
13.5.1 EVOLVING REGULATORY GUIDELINES ON PATIENT SAFETY BY REGULATORY BODIES TO PROPEL SEGMENT GROWTH
TABLE 62 PATIENT REGISTRY SOFTWARE MARKET FOR PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
13.6 RESEARCH CENTERS
13.6.1 INCREASED CLINICAL TRIALS & RESEARCH ON DISEASE TREATMENT SUPPORTS GROWTH
TABLE 63 PATIENT REGISTRY SOFTWARE MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
14 PATIENT REGISTRY SOFTWARE MARKET, BY REGION
14.1 INTRODUCTION
FIGURE 27 PATIENT REGISTRY SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 64 PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2019–2026 (USD MILLION)
14.2 NORTH AMERICA
FIGURE 28 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT
TABLE 65 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 66 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 67 NORTH AMERICA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 68 NORTH AMERICA: DISEASE REGISTRIES MARKET, BY TYPE, –2026 (USD MILLION)
TABLE 69 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 70 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 71 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 72 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 73 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 74 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.2.1 US
14.2.1.1 Largest market for patient registry software
TABLE 75 US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 76 US: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 77 US: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 78 US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 79 US: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 80 US: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 81 US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 82 US: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 83 US: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.2.2 CANADA
14.2.2.1 Launch of new government initiatives is expected to drive the adoption of patient registry software across the country
TABLE 84 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 85 CANADA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 CANADA: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 87 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 88 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 89 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 90 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 91 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 92 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3 EUROPE
TABLE 93 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 94 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 95 EUROPE: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 96 EUROPE: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 97 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 98 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 99 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 100 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 101 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 102 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3.1 GERMANY
14.3.1.1 High healthcare spending to support adoption of patient registry software solutions
TABLE 103 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 104 GERMANY: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 105 GERMANY: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 106 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 107 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 108 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 109 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 110 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 111 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3.2 UK
14.3.2.1 Government initiatives to support market growth
TABLE 112 UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 113 UK: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 114 UK: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 115 UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 116 UK: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 117 UK: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 118 UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 119 UK: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 120 UK: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3.3 FRANCE
14.3.3.1 Large number of COVID-19 cases to support market growth
TABLE 121 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 122 FRANCE: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 123 FRANCE: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 124 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 125 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 126 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 127 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 128 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 129 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3.4 ITALY
14.3.4.1 Rising prevalence of chronic diseases to increase demand for patient registry software
TABLE 130 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 131 ITALY: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 132 ITALY: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 133 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 134 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 135 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 136 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 137 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 138 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3.5 SPAIN
14.3.5.1 Government initiatives to improve adoption of patient registry software and eHealth solutions to drive demand
TABLE 139 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 140 SPAIN: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 141 SPAIN: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 142 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 143 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 144 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 145 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 146 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 147 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3.6 REST OF EUROPE
TABLE 148 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 149 ROE: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 150 ROE: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 151 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 152 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 153 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 154 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 155 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 156 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.4 ASIA PACIFIC
FIGURE 29 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT
TABLE 157 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 158 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 159 ASIA PACIFIC: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 160 ASIA PACIFIC: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 161 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 162 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 163 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 164 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 165 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 166 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2019–2026 (USD MILLION)
14.4.1 JAPAN
14.4.1.1 Highest adoption rates of EMR and patient registry software solutions
TABLE 167 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 168 JAPAN: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 169 JAPAN: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 170 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 171 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 172 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 173 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 174 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 175 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2019–2026 (USD MILLION)
14.4.2 CHINA
14.4.2.1 Absence of a patient-centered model may challenge adoption of patient registry software
TABLE 176 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 177 CHINA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 178 CHINA: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 179 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 180 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 181 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 182 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 183 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 184 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2019–2026 (USD MILLION)
14.4.3 INDIA
14.4.3.1 One of the lucrative markets in eHealth field
TABLE 185 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 186 INDIA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 187 INDIA: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 188 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 189 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 190 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 191 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 192 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 193 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2019–2026 (USD MILLION)
14.4.4 REST OF ASIA PACIFIC
TABLE 194 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 195 ROAPAC: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 196 ROAPAC: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 197 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 198 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 199 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 200 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 201 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 202 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2019–2026 (USD MILLION)
14.5 LATIN AMERICA
14.5.1 LOW ADOPTION RATE OF EHR SOLUTIONS
TABLE 203 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 204 LATIN AMERICA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 205 LATIN AMERICA: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 206 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 207 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 208 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 209 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 210 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 211 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2019–2026 (USD MILLION)
14.6 MIDDLE EAST & AFRICA
14.6.1 GROWING GOVERNMENT INVESTMENTS DRIVING ADOPTION OF PATIENT REGISTRIES
TABLE 212 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 213 MIDDLE EAST & AFRICA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 214 MIDDLE EAST & AFRICA: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 215 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 216 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 217 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 218 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 219 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 220 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2019–2026 (USD MILLION)
15 COMPETITIVE LANDSCAPE
15.1 OVERVIEW
FIGURE 30 KEY PLAYER STRATEGIES
15.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 31 REVENUE ANALYSIS OF TOP PLAYERS IN PATIENT REGISTRY SOFTWARE MARKET
15.3 MARKET SHARE ANALYSIS
FIGURE 32 PATIENT REGISTRY SOFTWARE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
15.4 COMPETITIVE LEADERSHIP MAPPING
15.4.1 STARS
15.4.2 EMERGING LEADERS
15.4.3 PERVASIVE PLAYERS
15.4.4 PARTICIPANTS
FIGURE 33 PATIENT REGISTRY SOFTWARE MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
15.5 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS
15.5.1 PROGRESSIVE COMPANIES
15.5.2 DYNAMIC COMPANIES
15.5.3 STARTING BLOCKS
15.5.4 RESPONSIVE COMPANIES
FIGURE 34 PATIENT REGISTRY SOFTWARE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2020)
15.6 COMPETITIVE SCENARIO
15.6.1 PRODUCT LAUNCHES AND APPROVALS
TABLE 221 PRODUCT LAUNCHES & APPROVALS
15.6.2 DEALS
TABLE 222 DEALS (2018–2021)
15.7 COMPETITIVE BENCHMARKING
FIGURE 35 FOOTPRINTS OF COMPANY IN PATIENT REGISTRY SOFTWARE MARKET
TABLE 223 COMPANY BY TYPE OF REGISTRY FOOTPRINT (25 COMPANIES)
TABLE 224 COMPANY BY REGIONAL FOOTPRINT (25 COMPANIES)
16 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
16.1 IBM CORPORATION
FIGURE 36 IBM: COMPANY SNAPSHOT (2020)
16.2 IQVIA HOLDINGS
FIGURE 37 IQVIA HOLDINGS: COMPANY SNAPSHOT (2020)
16.3 OPENTEXT CORPORATION
FIGURE 38 OPENTEXT CORPORATION: COMPANY SNAPSHOT (2020)
16.4 OPTUM
FIGURE 39 OPTUM: COMPANY SNAPSHOT (2020)
16.5 PREMIER INC.
FIGURE 40 PREMIER: COMPANY SNAPSHOT
16.6 SYNEOS HEALTH
FIGURE 41 SYNEOS HEALTH: COMPANY SNAPSHOT (2020)
16.7 FIGMD
16.8 IMAGETREND, INC.
16.9 DACIMA SOFTWARE, INC.
16.10 GLOBAL VISION TECHNOLOGIES, INC.
16.11 IFA SYSTEMS AG
FIGURE 42 IFA SYSTEMS AG: COMPANY SNAPSHOT (2020)
16.12 MEDSTREAMING- M2S
16.13 MCKESSON CORPORATION
FIGURE 43 MCKESSON CORPORATION: COMPANY SNAPSHOT (2020)
16.14 EVADO CLINICAL
16.15 WIRB COPERNICUS GROUP
16.16 ARBORMETRIX, INC.
16.17 CONDUENT, INC.
FIGURE 44 CONDUENT INC: COMPANY SNAPSHOT (2020)
16.18 ELEKTA AB
FIGURE 45 ELEKTA AB: COMPANY SNAPSHOT (2020)
16.19 ORDINAL DATA, INC.
16.20 ESO SOLUTIONS
16.21 LUMEDX
16.22 ARMUS CORP
16.23 CEDARON
16.24 PHAMAX AG
16.25 VERSAFORM SYSTEMS CORP
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
17 APPENDIX
17.1 INSIGHTS OF INDUSTRY EXPERTS
17.2 DISCUSSION GUIDE
17.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.4 AVAILABLE CUSTOMIZATIONS
17.5 RELATED REPORTS
17.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKET SEGMENTATION
FIGURE 1 PATIENT REGISTRY SOFTWARE MARKET
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
TABLE 1 EXCHANGE RATES USED FOR CONVERSION TO USD
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE PATIENT REGISTRY SOFTWARE MARKET (2021-2026)
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 8 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: PATIENT REGISTRY SOFTWARE MARKET
3 EXECUTIVE SUMMARY
FIGURE 9 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2021 VS. 2026 (USD MILLION)
FIGURE 10 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2021 VS. 2026 (USD MILLION)
FIGURE 11 PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2021 VS. 2026 (USD MILLION)
FIGURE 12 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2021 VS. 2026 (USD MILLION)
FIGURE 13 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2021 VS. 2026 (USD MILLION)
FIGURE 14 PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021 VS. 2026 (USD MILLION)
FIGURE 15 PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF PATIENT REGISTRY SOFTWARE MARKET
4 PREMIUM INSIGHTS
4.1 PATIENT REGISTRY SOFTWARE MARKET OVERVIEW
FIGURE 17 RISING ADOPTION OF ELECTRONIC HEALTH RECORDS AND OTHER E-HEALTH SOLUTIONS DRIVING MARKET
4.2 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY AND COUNTRY (2020)
FIGURE 18 DISEASE REGISTRIES SEGMENT AND JAPAN ACCOUNTED
FOR LARGEST SHARES
4.3 PATIENT REGISTRY SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
4.4 REGIONAL MIX: PATIENT REGISTRY SOFTWARE MARKET (2021?2026)
FIGURE 20 NORTH AMERICA TO DOMINATE PATIENT REGISTRY
SOFTWARE MARKET IN 2026
4.5 PATIENT REGISTRY SOFTWARE MARKET: DEVELOPING VS. DEVELOPED MARKETS
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 PATIENT REGISTRY SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Government initiatives to build patient registries
5.2.1.2 Rising pressure to improve quality of care and reduce
healthcare costs
5.2.1.3 Rising adoption of EHRs and other eHealth solutions
5.2.1.4 Growing patient volume due to global outbreak of COVID-19
5.2.1.5 Growing use of patient registry data for post-marketing surveillance
5.2.2 MARKET RESTRAINTS
5.2.2.1 Privacy- and data security-related concerns
5.2.2.2 Shortage of trained and skilled resources
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Rising number of accountable care organizations
5.2.3.2 Emergence of cloud-based patient registry solutions
5.2.3.3 High adoption rate of subscription model
5.2.4 MARKET CHALLENGES
5.2.4.1 Lack of interoperability and integration
5.2.4.2 Reluctance to adopt advanced solutions
5.2.4.3 Lack of awareness
5.3 REGULATORY ANALYSIS
TABLE 3 KEY REGULATIONS & STANDARDS GOVERNING MEDICAL DEVICE CONNECTIVITY SOLUTIONS
5.3.1 INTEROPERABILITY STANDARDS
TABLE 4 KEY STANDARDS FOR INTEROPERABILITY IN DIGITAL HEALTH SPECTRUM
TABLE 5 QUALITATIVE ANALYSIS OF WIDELY USED DATA TRANSMISSION STANDARDS IN DIGITAL HEALTH SPECTRUM
5.4 PRICING ANALYSIS
5.5 TECHNOLOGY ANALYSIS
5.6 ECOSYSTEM ANALYSIS
FIGURE 23 ECOSYSTEM ANALYSIS: PATIENT REGISTRY SOFTWARE MARKET
5.7 PATENT ANALYSIS
5.7.1 PATENT PUBLICATION TRENDS FOR PATIENT REGISTRY SOFTWARE
FIGURE 24 PATENT PUBLICATION TRENDS (JANUARY 2011–JUNE 2021)
5.7.2 JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 25 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR PATIENT REGISTRIES PATENTS (JANUARY 2011 TO JUNE 2021)
FIGURE 26 TOP APPLICANT COUNTRIES/REGIONS FOR PATIENT REGISTRY SOFTWARE PATENTS (JANUARY 2011 TO JUNE 2021)
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 SHIFTING FOCUS TOWARD PATIENT-POWERED RESEARCH NETWORKS
6.2.2 GROWING DEVELOPMENTS IN AUTOMATED DATA ENTRIES
6.3 IMPACT OF COVID-19 ON PATIENT REGISTRY SOFTWARE MARKET
7 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY
7.1 INTRODUCTION
TABLE 6 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 7 PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2 DISEASE REGISTRIES
TABLE 8 DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 9 DISEASE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.1 DIABETES REGISTRIES
7.2.1.1 Growing obese and geriatric populations to drive market growth
TABLE 10 DIABETES REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 11 DIABETES REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2 CARDIOVASCULAR REGISTRIES
7.2.2.1 Rising prevalence of heart diseases and strokes worldwide to drive market growth
TABLE 12 CARDIOVASCULAR REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 13 CARDIOVASCULAR REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.3 CANCER REGISTRIES
7.2.3.1 Increasing need to manage growing number of cancer patients to propel market growth
TABLE 14 CANCER REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 15 CANCER REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.4 RARE DISEASE REGISTRIES
7.2.4.1 Increasing funding for research on rare diseases and their treatments to boost market growth
TABLE 16 RARE DISEASE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 17 RARE DISEASE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.5 ASTHMA REGISTRIES
7.2.5.1 Increasing prevalence of asthma significantly driving market growth
TABLE 18 ASTHMA REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 19 ASTHMA REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.6 CHRONIC KIDNEY DISEASE REGISTRIES
7.2.6.1 Rising prevalence of chronic kidney diseases to drive market growth
TABLE 20 CHRONIC KIDNEY DISEASE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 21 CHRONIC KIDNEY DISEASE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.7 ORTHOPEDIC REGISTRIES
7.2.7.1 Growing number of patients suffering from orthopedic diseases to drive market growth
TABLE 22 ORTHOPEDIC REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 23 ORTHOPEDIC REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.8 OTHER DISEASE REGISTRIES
TABLE 24 OTHER DISEASE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 HEALTH SERVICE REGISTRIES
7.3.1 CAPTURE SERVICE-GENERATED DATA DERIVED FROM HEALTH FACILITIES
TABLE 25 HEALTH SERVICE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 26 HEALTH SERVICE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4 PRODUCT REGISTRIES
TABLE 27 PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 28 PRODUCT REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.1 MEDICAL DEVICE REGISTRIES
7.4.1.1 Strong government support and initiatives to drive demand for medical device registries
TABLE 29 MEDICAL DEVICE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 30 MEDICAL DEVICE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.2 DRUG REGISTRIES
7.4.2.1 Increasing post-marketing surveillance of drugs to
drive market growth
TABLE 31 DRUGS REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 32 DRUG REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
8 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE
8.1 INTRODUCTION
TABLE 33 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
8.2 STANDALONE SOFTWARE
8.2.1 STANDALONE SOFTWARE TO DOMINATE MARKET IN FORECAST PERIOD
TABLE 34 STANDALONE SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 35 STANDALONE PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 INTEGRATED SOFTWARE
8.3.1 INTEGRATED SOFTWARE SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
TABLE 36 INTEGRATED SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 37 INTEGRATED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
9 PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL
9.1 INTRODUCTION
TABLE 38 PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
9.2 SUBSCRIPTION MODEL
9.2.1 LOW COST OF SUBSCRIPTION MODELS TO SUPPORT SEGMENT GROWTH
TABLE 39 SUBSCRIPTION-BASED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
9.3 OWNERSHIP MODEL
9.3.1 RISING ADOPTION OF INTEGRATED SOFTWARE MODEL TO SUPPORT SEGMENT GROWTH
TABLE 40 OWNERSHIP-BASED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
10 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL
10.1 INTRODUCTION
TABLE 41 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
10.2 ON-PREMISE MODEL
10.2.1 ON-PREMISE SOLUTIONS REDUCE RISK OF DATA BREACHES AND OTHER SECURITY ISSUES
TABLE 42 ON-PREMISE PATIENT REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 43 ON-PREMISE PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
10.3 CLOUD-BASED MODEL
10.3.1 CLOUD-BASED SOLUTIONS HELP HEALTHCARE ORGANIZATIONS SHARE AND INTEGRATE INFORMATION FROM DISPARATE LOCATIONS IN REAL-TIME
TABLE 44 CLOUD-BASED PATIENT REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 45 CLOUD-BASED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
11 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE
11.1 INTRODUCTION
TABLE 46 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
11.2 COMMERCIAL DATABASES
11.2.1 COMMERCIAL REGISTRIES ARE GENERALLY PRIVATELY FUNDED OR INDUSTRY-SPONSORED
TABLE 47 PATIENT REGISTRY SOFTWARE FOR COMMERCIAL DATABASES OFFERED
BY KEY MARKET PLAYERS
TABLE 48 PATIENT REGISTRY SOFTWARE MARKET FOR COMMERCIAL DATABASES, BY COUNTRY, 2019–2026 (USD MILLION)
11.3 PUBLIC DATABASES
11.3.1 PUBLIC REGISTRIES ARE FUNDED BY FEDERAL, STATE, OR LOCAL GOVERNMENT AGENCIES
TABLE 49 PATIENT REGISTRY SOFTWARE FOR PUBLIC DATABASES OFFERED
BY KEY MARKET PLAYERS
TABLE 50 PATIENT REGISTRY SOFTWARE MARKET FOR PUBLIC DATABASES, BY COUNTRY, 2019–2026 (USD MILLION)
12 PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY
12.1 INTRODUCTION
TABLE 51 PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
12.2 POPULATION HEALTH MANAGEMENT
12.2.1 INCREASING DEMAND FOR QUALITY CARE DRIVES ADOPTION
OF PHM SOLUTIONS
TABLE 52 PATIENT REGISTRY SOFTWARE MARKET FOR POPULATION HEALTH MANAGEMENT, BY COUNTRY, 2019–2026 (USD MILLION)
12.3 PATIENT CARE MANAGEMENT
12.3.1 GOVERNMENT INITIATIVES AND REGULATIONS PROMOTING PATIENT-CENTRIC CARE TO DRIVE MARKET GROWTH
TABLE 53 PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT CARE MANAGEMENT, BY COUNTRY, 2019–2026 (USD MILLION)
12.4 MEDICAL RESEARCH & CLINICAL STUDIES
12.4.1 CONTINUOUS RESEARCH FOR COVID-19 VACCINE SUPPORTING
SEGMENT GROWTH
TABLE 54 PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL RESEARCH & CLINICAL STUDIES, BY COUNTRY, 2019–2026 (USD MILLION)
12.5 HEALTH INFORMATION EXCHANGE
12.5.1 INCREASING NEED FOR SHARING OF VITAL PATIENT INFORMATION WITH CARE PROVIDERS SUPPORTS ADOPTION OF SOLUTIONS
TABLE 55 PATIENT REGISTRY SOFTWARE MARKET FOR HEALTH INFORMATION EXCHANGE, BY COUNTRY, 2019–2026 (USD MILLION)
12.6 POINT OF CARE
12.6.1 URGENT NEED FOR STREAMLINED PATIENT CARE PROCESS
TO DRIVE GROWTH
TABLE 56 PATIENT REGISTRY SOFTWARE MARKET FOR POINT OF CARE, BY COUNTRY, 2019–2026 (USD MILLION)
12.7 PRODUCT OUTCOME EVALUATION
12.7.1 INCREASING POST-MARKETING SURVEILLANCE IN BIOTECHNOLOGY AND MEDICAL DEVICE COMPANIES TO PROPEL MARKET GROWTH
TABLE 57 PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT OUTCOME EVALUATION, BY COUNTRY, 2019–2026 (USD MILLION)
13 PATIENT REGISTRY SOFTWARE MARKET, BY END-USER
13.1 INTRODUCTION
TABLE 58 PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2019–2026 (USD MILLION)
13.2 GOVERNMENT ORGANIZATIONS & THIRD-PARTY ADMINISTRATORS
13.2.1 GOVERNMENT ORGANIZATIONS & THIRD-PARTY ADMINISTRATORS HOLD LARGEST SHARE IN END-USER MARKET
TABLE 59 PATIENT REGISTRY SOFTWARE MARKET FOR GOVERNMENT ORGANIZATIONS & TPAS, BY COUNTRY, 2019–2026 (USD MILLION)
13.3 HOSPITALS & MEDICAL PRACTICES
13.3.1 DEMAND FOR REGISTRY SOFTWARE SUPPORTED BY A GROWING FOCUS ON PATIENT SAFETY AND IMPROVING PATIENT OUTCOMES
TABLE 60 PATIENT REGISTRY SOFTWARE MARKET FOR HOSPITALS & MEDICAL PRACTICES, BY COUNTRY, 2019–2026 (USD MILLION)
13.4 PRIVATE PAYERS
13.4.1 NEED TO CURB RISING HEALTHCARE COSTS TO DRIVE MARKET GROWTH
TABLE 61 PATIENT REGISTRY SOFTWARE MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2019–2026 (USD MILLION)
13.5 PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES
13.5.1 EVOLVING REGULATORY GUIDELINES ON PATIENT SAFETY BY REGULATORY BODIES TO PROPEL SEGMENT GROWTH
TABLE 62 PATIENT REGISTRY SOFTWARE MARKET FOR PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
13.6 RESEARCH CENTERS
13.6.1 INCREASED CLINICAL TRIALS & RESEARCH ON DISEASE TREATMENT SUPPORTS GROWTH
TABLE 63 PATIENT REGISTRY SOFTWARE MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
14 PATIENT REGISTRY SOFTWARE MARKET, BY REGION
14.1 INTRODUCTION
FIGURE 27 PATIENT REGISTRY SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 64 PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2019–2026 (USD MILLION)
14.2 NORTH AMERICA
FIGURE 28 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT
TABLE 65 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 66 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 67 NORTH AMERICA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 68 NORTH AMERICA: DISEASE REGISTRIES MARKET, BY TYPE, –2026 (USD MILLION)
TABLE 69 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 70 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 71 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 72 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 73 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 74 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.2.1 US
14.2.1.1 Largest market for patient registry software
TABLE 75 US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 76 US: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 77 US: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 78 US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 79 US: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 80 US: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 81 US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 82 US: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 83 US: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.2.2 CANADA
14.2.2.1 Launch of new government initiatives is expected to drive the adoption of patient registry software across the country
TABLE 84 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 85 CANADA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 CANADA: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 87 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 88 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 89 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 90 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 91 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 92 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3 EUROPE
TABLE 93 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 94 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 95 EUROPE: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 96 EUROPE: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 97 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 98 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 99 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 100 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 101 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 102 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3.1 GERMANY
14.3.1.1 High healthcare spending to support adoption of patient registry software solutions
TABLE 103 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 104 GERMANY: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 105 GERMANY: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 106 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 107 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 108 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 109 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 110 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 111 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3.2 UK
14.3.2.1 Government initiatives to support market growth
TABLE 112 UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 113 UK: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 114 UK: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 115 UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 116 UK: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 117 UK: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 118 UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 119 UK: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 120 UK: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3.3 FRANCE
14.3.3.1 Large number of COVID-19 cases to support market growth
TABLE 121 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 122 FRANCE: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 123 FRANCE: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 124 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 125 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 126 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 127 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 128 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 129 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3.4 ITALY
14.3.4.1 Rising prevalence of chronic diseases to increase demand for patient registry software
TABLE 130 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 131 ITALY: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 132 ITALY: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 133 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 134 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 135 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 136 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 137 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 138 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3.5 SPAIN
14.3.5.1 Government initiatives to improve adoption of patient registry software and eHealth solutions to drive demand
TABLE 139 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 140 SPAIN: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 141 SPAIN: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 142 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 143 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 144 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 145 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 146 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 147 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3.6 REST OF EUROPE
TABLE 148 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 149 ROE: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 150 ROE: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 151 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 152 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 153 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 154 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 155 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 156 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.4 ASIA PACIFIC
FIGURE 29 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT
TABLE 157 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 158 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 159 ASIA PACIFIC: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 160 ASIA PACIFIC: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 161 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 162 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 163 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 164 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 165 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 166 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2019–2026 (USD MILLION)
14.4.1 JAPAN
14.4.1.1 Highest adoption rates of EMR and patient registry software solutions
TABLE 167 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 168 JAPAN: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 169 JAPAN: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 170 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 171 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 172 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 173 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 174 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 175 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2019–2026 (USD MILLION)
14.4.2 CHINA
14.4.2.1 Absence of a patient-centered model may challenge adoption of patient registry software
TABLE 176 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 177 CHINA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 178 CHINA: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 179 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 180 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 181 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 182 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 183 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 184 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2019–2026 (USD MILLION)
14.4.3 INDIA
14.4.3.1 One of the lucrative markets in eHealth field
TABLE 185 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 186 INDIA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 187 INDIA: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 188 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 189 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 190 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 191 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 192 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 193 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2019–2026 (USD MILLION)
14.4.4 REST OF ASIA PACIFIC
TABLE 194 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 195 ROAPAC: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 196 ROAPAC: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 197 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 198 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 199 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 200 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 201 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 202 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2019–2026 (USD MILLION)
14.5 LATIN AMERICA
14.5.1 LOW ADOPTION RATE OF EHR SOLUTIONS
TABLE 203 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 204 LATIN AMERICA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 205 LATIN AMERICA: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 206 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 207 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 208 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 209 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 210 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 211 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2019–2026 (USD MILLION)
14.6 MIDDLE EAST & AFRICA
14.6.1 GROWING GOVERNMENT INVESTMENTS DRIVING ADOPTION OF PATIENT REGISTRIES
TABLE 212 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 213 MIDDLE EAST & AFRICA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 214 MIDDLE EAST & AFRICA: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 215 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 216 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 217 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 218 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 219 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 220 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2019–2026 (USD MILLION)
15 COMPETITIVE LANDSCAPE
15.1 OVERVIEW
FIGURE 30 KEY PLAYER STRATEGIES
15.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 31 REVENUE ANALYSIS OF TOP PLAYERS IN PATIENT REGISTRY SOFTWARE MARKET
15.3 MARKET SHARE ANALYSIS
FIGURE 32 PATIENT REGISTRY SOFTWARE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
15.4 COMPETITIVE LEADERSHIP MAPPING
15.4.1 STARS
15.4.2 EMERGING LEADERS
15.4.3 PERVASIVE PLAYERS
15.4.4 PARTICIPANTS
FIGURE 33 PATIENT REGISTRY SOFTWARE MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
15.5 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS
15.5.1 PROGRESSIVE COMPANIES
15.5.2 DYNAMIC COMPANIES
15.5.3 STARTING BLOCKS
15.5.4 RESPONSIVE COMPANIES
FIGURE 34 PATIENT REGISTRY SOFTWARE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2020)
15.6 COMPETITIVE SCENARIO
15.6.1 PRODUCT LAUNCHES AND APPROVALS
TABLE 221 PRODUCT LAUNCHES & APPROVALS
15.6.2 DEALS
TABLE 222 DEALS (2018–2021)
15.7 COMPETITIVE BENCHMARKING
FIGURE 35 FOOTPRINTS OF COMPANY IN PATIENT REGISTRY SOFTWARE MARKET
TABLE 223 COMPANY BY TYPE OF REGISTRY FOOTPRINT (25 COMPANIES)
TABLE 224 COMPANY BY REGIONAL FOOTPRINT (25 COMPANIES)
16 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
16.1 IBM CORPORATION
FIGURE 36 IBM: COMPANY SNAPSHOT (2020)
16.2 IQVIA HOLDINGS
FIGURE 37 IQVIA HOLDINGS: COMPANY SNAPSHOT (2020)
16.3 OPENTEXT CORPORATION
FIGURE 38 OPENTEXT CORPORATION: COMPANY SNAPSHOT (2020)
16.4 OPTUM
FIGURE 39 OPTUM: COMPANY SNAPSHOT (2020)
16.5 PREMIER INC.
FIGURE 40 PREMIER: COMPANY SNAPSHOT
16.6 SYNEOS HEALTH
FIGURE 41 SYNEOS HEALTH: COMPANY SNAPSHOT (2020)
16.7 FIGMD
16.8 IMAGETREND, INC.
16.9 DACIMA SOFTWARE, INC.
16.10 GLOBAL VISION TECHNOLOGIES, INC.
16.11 IFA SYSTEMS AG
FIGURE 42 IFA SYSTEMS AG: COMPANY SNAPSHOT (2020)
16.12 MEDSTREAMING- M2S
16.13 MCKESSON CORPORATION
FIGURE 43 MCKESSON CORPORATION: COMPANY SNAPSHOT (2020)
16.14 EVADO CLINICAL
16.15 WIRB COPERNICUS GROUP
16.16 ARBORMETRIX, INC.
16.17 CONDUENT, INC.
FIGURE 44 CONDUENT INC: COMPANY SNAPSHOT (2020)
16.18 ELEKTA AB
FIGURE 45 ELEKTA AB: COMPANY SNAPSHOT (2020)
16.19 ORDINAL DATA, INC.
16.20 ESO SOLUTIONS
16.21 LUMEDX
16.22 ARMUS CORP
16.23 CEDARON
16.24 PHAMAX AG
16.25 VERSAFORM SYSTEMS CORP
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
17 APPENDIX
17.1 INSIGHTS OF INDUSTRY EXPERTS
17.2 DISCUSSION GUIDE
17.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.4 AVAILABLE CUSTOMIZATIONS
17.5 RELATED REPORTS
17.6 AUTHOR DETAILS
